<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01051258</url>
  </required_header>
  <id_info>
    <org_study_id>03-C08-003PLVGP4-5</org_study_id>
    <secondary_id>03-C10-001PLV</secondary_id>
    <nct_id>NCT01051258</nct_id>
  </id_info>
  <brief_title>AeriSeal System for Lung Volume Reduction</brief_title>
  <official_title>A Study of the AeriSeal System for Lung Volume Reduction in Patients With Advanced Emphysema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aeris Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aeris Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of AeriSeal treatment in
      patients with advanced emphysema.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of AeriSeal treatment in
      patients with advanced homogeneous and heterogeneous emphysema.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in respiratory volume/total lung capacity (RV/TLC) ratio</measure>
    <time_frame>12 Weeks following final treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in RV/TLC ratio</measure>
    <time_frame>24 and 48 weeks following treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in forced expiratory volume in 1 second (FEV1) (post bronchodilator)</measure>
    <time_frame>12, 24, 48 weeks following treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in MRC dyspnea score</measure>
    <time_frame>12, 24, 48 weeks following treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in 6 minute walk test (MWT)</measure>
    <time_frame>12, 24, 48 weeks following treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in disease-specific health related quality of life assessment (SGRQ)</measure>
    <time_frame>12, 24, 48 weeks following treatment</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">55</enrollment>
  <condition>Emphysema</condition>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <condition>Pulmonary Emphysema</condition>
  <condition>Lung Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AeriSeal System</intervention_name>
    <description>AeriSeal System for Lung Volume Reduction</description>
    <other_name>lung volume reduction</other_name>
    <other_name>AeriSeal</other_name>
    <other_name>PLVR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have a diagnosis of advanced emphysema as defined by FEV1/FVC&lt;70%
             predicted, FEV1 of &lt;50% predicted, TLC &gt; 100% predicted, and RV &gt; 135% predicted.

          -  Patients must have persistent symptoms despite medical therapy and either not be
             candidates for Lung Volume Reduction Surgery (LVRS) or have elected not to undergo
             LVRS.

          -  Patients must be &gt; 40 years of age, have symptoms despite medical therapy, and have
             none of the prespecified co-morbid conditions that could influence study outcomes or
             their ability to tolerate bronchoscopy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Otto Wagner Spital Wien Interne Lungenabteilung</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chefarzt Klinik für Pneumologie</name>
      <address>
        <city>Bad Berka</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lungenklinik Hemer</name>
      <address>
        <city>Hemer</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik und Poliklinik Klinikum Großhadern</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center, Beilinson Hospital</name>
      <address>
        <city>Petach-Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
    <country>Italy</country>
  </removed_countries>
  <link>
    <url>http://www.aerist.com</url>
  </link>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2010</study_first_posted>
  <last_update_submitted>June 25, 2013</last_update_submitted>
  <last_update_submitted_qc>June 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Polymeric Lung Volume Reduction (PLVR)</keyword>
  <keyword>Biologic Lung Volume Reduction (BLVR)</keyword>
  <keyword>AeriSeal</keyword>
  <keyword>treatment</keyword>
  <keyword>device</keyword>
  <keyword>breathing</keyword>
  <keyword>COPD</keyword>
  <keyword>emphysema</keyword>
  <keyword>heterogeneous</keyword>
  <keyword>homogeneous</keyword>
  <keyword>Pathologic Processes</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Pulmonary Disease, Chronic Obstructive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

